SINGULAIR MSD 117 (Singulair 10 mg)
Generic Name: montelukast
Pill with imprint SINGULAIR MSD 117 is Brown, Four-sided and has been identified as Singulair 10 mg. It is supplied by Merck & Company Inc.
Singulair is used in the treatment of allergic rhinitis; bronchospasm prophylaxis; asthma; asthma, maintenance and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Singulair 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SINGULAIR MSD 117
Singulair
- Generic Name:
- montelukast
- Imprint:
- SINGULAIR MSD 117
- Strength:
- 10 mg
- Color:
- Brown
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Leukotriene modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Merck & Company Inc
- Inactive Ingredients:
- microcrystalline cellulose
lactose monohydrate
croscarmellose sodium
hydroxypropyl cellulose (type h)
magnesium stearate
hypromelloses
titanium dioxide
ferric oxide red
ferric oxide yellow
carnauba wax
Note: Inactive ingredients may vary.
More about Singulair (montelukast)
- Singulair Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 144 Reviews
- Generic Availability
- Drug class: leukotriene modifiers
- FDA Alerts (2)
Consumer resources
- Singulair
- Singulair (Montelukast Chewable Tablets)
- Singulair (Montelukast Oral Granules)
- Singulair (Montelukast Tablets)
- Singulair (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
